Clinical trial Recruiting at 1 site Interventional Ages 18 to 35 Women only

Postpartum Care Package delivered by chatbot and web program

Official title: Evaluation of the Effectiveness of a Chatbot-Supported Web-Based Postpartum Care Package Program for Postpartum Women

Run by Bozok University · NCT07148778 · Data updated 2026-11-12

A chatbot-delivered web program tests if a postpartum care package can improve health for new mothers and their babies and make care resources easier to access.

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexWomen only
Enrollment102 (estimated)
SponsorBozok University
Academic / other
Locations1 site (Yozgat, City Center)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedNovember 30, 2026
Study endsDecember 31, 2026
Registry record updatedOctober 16, 2026
Trial IDNCT07148778 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Primiparous women who recently delivered between 37 and 41 weeks, with basic literacy, and access to a mobile device or computer and internet, without high-risk pregnancy or major complications.

Probably not a fit

Women outside the geographic area, lacking device access, or with high-risk conditions or complications during pregnancy or postpartum may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates a web-based POSTPARTUM Care Package delivered via a chatbot to women who recently gave birth. It uses an educational intervention to support postpartum health in both mothers and newborns. Participants meet defined criteria and must have access to a device and internet, with the aim of improving resource accessibility and health outcomes through digital education. The study is conducted at Yozgat City Hospital with Emine Ilkin Aydin as lead sponsor and no listed collaborators.

Why it matters

Potential benefit: If successful, the program could help new mothers access postpartum resources more easily and potentially improve maternal and infant health outcomes.

How similar studies have gone: Previous similar digital postpartum education approaches have shown potential benefits, but results vary and this delivery via chatbot is a relatively modern approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: Women who will be included in the study.

* Have given birth between the 37th and 41st weeks of pregnancy,
* Be primigravida,
* Have not been diagnosed with a high-risk pregnancy,
* Have an educational level of primary school or above,
* Have no communication difficulties or mental disabilities,
* Have access to equipment (mobile phone, computer, tablet, internet) for web-based education,
* Have experienced no complications in the mother or baby during pregnancy, childbirth, or the postpartum period,
* Voluntarily agree to participate in the study,

Exclusion Criteria:

* Women who moved outside the province where the study was conducted during the implementation period,
* Women who voluntarily withdrew from the study,
* Women who did not participate in any phase of the study will not be included in the study.

Where it's running

  • Yozgat City Hospital
    Yozgat, City Center, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Emine ILKIN AYDIN, Lecturer — Yozgat Bozok University
  • Study coordinator: Emine ILKIN AYDIN, Lecturer
  • Email: emine.ilkin@yobu.edu.tr
  • Phone: +905456281694

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.